AB-Fortis® (Microencapsulated Iron — Frutarom)

Evidence Level
Moderate
1 Clinical Trial
5 Documented Benefits
3/5 Evidence Score

AB-Fortis® is a MICROENCAPSULATED FORM OF IRON developed by Frutarom Health (now IFF) — designed to fortify foods with iron without changing appearance, palatability, or taste. Distinguished by encapsulation technology that addresses iron's primary fortification challenges (metallic taste, color changes, GI side effects). Used for: iron deficiency replacement, anemia adjunct, food fortification, supplementation with improved palatability.

Studied Dose Per AB-Fortis product specification (typical 8-18 mg elemental iron/day)
Active Compound Microencapsulated iron

Benefits

Iron Deficiency Replacement

Iron is essential for hemoglobin synthesis, oxygen transport, energy metabolism. AB-Fortis provides bioavailable iron for deficiency replacement.

Improved Palatability

Encapsulation eliminates metallic taste of standard iron supplements — major improvement; particularly relevant for prenatal vitamins, multivitamins, pediatric formulations.

Food Fortification Without Sensory Changes

Suitable for fortifying foods (cereals, baked goods, beverages) without changing appearance, taste, or color.

Reduced Oxidation

Encapsulation reduces iron oxidation in food matrices and during digestion.

Reduced GI Side Effects

May reduce iron-related GI side effects (constipation, nausea) common with standard iron.

Mechanism of action

1

Iron Hemoglobin Function

Iron is essential cofactor in hemoglobin and myoglobin; deficiency causes microcytic anemia.

2

Iron Energy Metabolism

Iron is cofactor for cytochromes in mitochondrial electron transport — relevant to energy production.

3

Microencapsulation

Protects iron through GI tract; releases at appropriate location for absorption; reduces interaction with food matrix.

Clinical trials

1
AB-Fortis Bioavailability Studies — Frutarom

Frutarom clinical evaluation of AB-Fortis bioavailability and efficacy.

Adults including iron-deficient populations.

Bioavailability suitable for iron deficiency replacement; improved palatability vs unencapsulated iron.

About this ingredient

About the active ingredient

AB-FORTIS® is a MICROENCAPSULATED FORM OF IRON developed by FRUTAROM HEALTH (now IFF). IRON DEFICIENCY BACKGROUND: most common nutrient deficiency globally; affects up to 25% of world population; particularly common in: menstruating women, pregnant women, vegetarians/vegans, adolescent girls, blood donors.

KEY DISTINCTIONS: (1) MICROENCAPSULATION technology; (2) NEUTRAL TASTE (eliminates metallic taste); (3) STABLE in food matrices; (4) Reduced GI side effects.

EVIDENCE-BASED USES: (1) Iron deficiency replacement; (2) Food fortification; (3) Improved palatability supplementation; (4) Energy and oxygen transport support.

CRITICAL CAUTIONS: (1) IRON DEFICIENCY DIAGNOSIS — NEVER supplement iron without confirmed need (serum ferritin <30 ng/mL or formal diagnosis); HEMOCHROMATOSIS (genetic iron overload, 1 in 200) can be worsened by iron supplementation; (2) HEMOCHROMATOSIS — AVOID iron supplementation; (3) DRUG INTERACTIONS — separate from levothyroxine (4 hours), fluoroquinolones/tetracyclines (2 hours), calcium, zinc; (4) VITAMIN C ENHANCES ABSORPTION; (5) DOSE — typical 18 mg/day women, 8 mg/day men; therapeutic anemia doses higher under medical supervision; (6) PREGNANCY — iron needs higher; supplementation often recommended; consult prenatal care; (7) AB-FORTIS vs OTHER IRON FORMS — encapsulation distinguishes from generic iron sulfate (cheap, more side effects), iron bisglycinate (chelated, better tolerance); (8) BLACK STOOL — normal with iron supplementation; not melena (digested blood); (9) FOR FOOD FORTIFICATION — AB-Fortis suitable for breakfast cereals, baked goods, fortified beverages, infant formula; (10) BRAND VERIFICATION — AB-Fortis® is Frutarom/IFF trademark.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated; encapsulation reduces standard iron side effects.
Mild GI distress, constipation possible (less than standard iron).
Dark stool (normal with iron).
IRON OVERLOAD CONCERN — never supplement iron without confirmed need due to hemochromatosis risk.

Important Drug interactions

LEVOTHYROXINE — iron reduces absorption; separate by 4 hours.
FLUOROQUINOLONES, TETRACYCLINES — iron reduces absorption; separate by 2 hours.
CALCIUM SUPPLEMENTS — calcium reduces iron absorption; separate timing.
ZINC SUPPLEMENTS — competition for absorption; separate timing.
PPIs / antacids — reduced gastric acid impairs iron absorption.
VITAMIN C — enhances non-heme iron absorption (positive interaction).
Pregnancy — iron deficiency common; supplementation often appropriate; consult prenatal care.
HEMOCHROMATOSIS — AVOID iron supplementation in this condition.

Frequently asked questions about AB-Fortis® (Microencapsulated Iron — Frutarom)

What is the recommended dosage of AB-Fortis® (Microencapsulated Iron — Frutarom)?

The clinically studied dose for AB-Fortis® (Microencapsulated Iron — Frutarom) is Per AB-Fortis product specification (typical 8-18 mg elemental iron/day). Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is AB-Fortis® (Microencapsulated Iron — Frutarom) used for?

AB-Fortis® (Microencapsulated Iron — Frutarom) is studied for iron deficiency replacement, improved palatability, food fortification without sensory changes. Iron is essential for hemoglobin synthesis, oxygen transport, energy metabolism. AB-Fortis provides bioavailable iron for deficiency replacement.

Are there side effects from taking AB-Fortis® (Microencapsulated Iron — Frutarom)?

Reported potential side effects may include: Generally well-tolerated; encapsulation reduces standard iron side effects. Mild GI distress, constipation possible (less than standard iron). Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does AB-Fortis® (Microencapsulated Iron — Frutarom) interact with medications?

Known drug interactions may include: LEVOTHYROXINE — iron reduces absorption; separate by 4 hours. FLUOROQUINOLONES, TETRACYCLINES — iron reduces absorption; separate by 2 hours. Consult a pharmacist or healthcare provider if you take prescription medications.

Is AB-Fortis® (Microencapsulated Iron — Frutarom) good for energy?

Yes, AB-Fortis® (Microencapsulated Iron — Frutarom) is researched for Energy support. Iron is essential for hemoglobin synthesis, oxygen transport, energy metabolism. AB-Fortis provides bioavailable iron for deficiency replacement.